Skip to Content
Merck
  • Eps8 controls Src- and FAK-dependent phenotypes in squamous carcinoma cells.

Eps8 controls Src- and FAK-dependent phenotypes in squamous carcinoma cells.

Journal of cell science (2014-11-02)
Christina Schoenherr, Bryan Serrels, Charlotte Proby, Debbie L Cunningham, Jane E Findlay, George S Baillie, John K Heath, Margaret C Frame
ABSTRACT

Eps8 is an actin regulatory scaffold protein whose expression is increased in squamous cell carcinoma (SCC) cells. It forms a complex with both focal adhesion kinase (FAK, also known as PTK2) and Src in SCC cells derived from skin carcinomas induced by administration of the chemical DMBA followed by TPA (the DMBA/TPA model). Here, we describe two new roles for Eps8. Firstly, it controls the spatial distribution of active Src in a FAK-dependent manner. Specifically, Eps8 participates in, and regulates, a biochemical complex with Src and drives trafficking of Src to autophagic structures that SCC cells use to cope with high levels of active Src when FAK is absent. Secondly, when FAK is expressed in SCC cells, thereby meaning active Src becomes tethered at focal adhesion complexes, Eps8 is also recruited to focal adhesions and is required for FAK-dependent polarization and invasion. Therefore, Eps8 is a crucial mediator of Src- and FAK-regulated processes; it participates in specific biochemical complexes and promotes actin re-arrangements that determine the spatial localization of Src, and modulates the functions of Src and FAK during invasive migration.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-EPS8 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-EPS8 (C-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution